False positive and false negative immunochemical findings: A permanent risk of analytical pitfalls

Japanese Journal of Forensic Toxicology

Volumn 18, Issue 1, 2000, Pages 14-20

  Schütz, Harald ^a   Erdmann, Freidoon ^a   Rochholz, Gertrud ^b   Weiler, Günter ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Benzodiazepines Cocaine; False negative; False positive; Immunoassays; Opiates; Screening

Indexed keywords

ALPRAZOLAM; ILLICIT DRUG; TRIAZOLAM;

ANALYTIC METHOD; ANTIBODY AFFINITY; CROSS REACTION; DERIVATIZATION; ENZYME IMMUNOASSAY; FLUORESCENCE POLARIZATION IMMUNOASSAY; HYDROLYSIS; IMMUNOCHEMISTRY; LABORATORY TEST; RADIOIMMUNOASSAY; RISK ASSESSMENT; SCREENING; SHORT SURVEY;

EID: 0034017605     PISSN: 09159606     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (15)

1. Schütz, H.: Screening von Drogen und Arzneimitteln mit Immunoassays. Wissenschaftliche Verlagsabteilung Abbott, Wiesbaden, 1999.
2. Krämer, T., Bock, K., Wennig, R. and Maurer, H.H.: The antispasmodic mebeverine leads to positive amphetamine results with the fluorescence polarization immuno assay - Studies on the metabolism and the toxicological detection in urine by GC/MS and FPIA. XI Symposium der GTFCh, 1999, pp. 34-43.
3. Rochholz, G. and Schütz, H.W.: in preparation.
4. Matuch-Hite, T., Jones, P., Jr. and Moriarity, J.: Interference of oxaprozin with benzodiazepines via enzyme immunoassay technique. J Anal Toxicol, 19, 130 (1995).
5. Nishikawa, T., Kamijo, Y., Ohtani, H. and Fraser, A.D.: Oxaprozin interference with urinary benzodiazepine immunoassay and noninterference with receptor assay. J Anal Toxicol, 23, 125-126 (1999).
6. Al-Amri, A.M. and El-Haj, B.M.: Positive interference of the analgesic drug nefopam in the enzyme immunoassay (EMIT D.A.U.) for benzodiazepines. Bull Int Assoc Forensic Toxicol, 29 (1), 4 (1999).
7. Röhrich, J., Zörntlein, S., Lotz, J., Becker, J., Kern, T. and Rittner, C.: False-positive LSD testing in urine samples from intensive care patients. J Anal Toxicol, 22, 393-395 (1998).
8. Bogusz, M., Maier, R.D. and Hoenen, H.: Positive LSD immunoassay after sertraline intake. Bull Int Assoc Forensic Toxicol, 28 (3), 11-12 (1998).
9. Moorman, P., McCoy, M., Hague, B. and Huge, D.: Disopyramide cross-reactivity in a commercial immunoassay reagent for methadone. J Anal Toxicol, 23, 299-300 (1999).
10. Meatherall, R. and Dai, J.: False-positive EMIT II opiates from ofloxacin. Ther Drug Monit, 19, 98-99 (1997).
11. Mura, P., Kintz, P., Robert, R. and Papet, Y.: Buflomedil is a potent interfering substance in immunoassays of tricyclic antidepressants. J Anal Toxicol, 22, 254 (1998).
12. Schütz, H.: Screening of Drugs with Immunoassays. Guidelines for Practical Work, Abbott, Wiesbaden, 1992.
13. 18 cartridges and wide-bore capillary gas chromatography of benzophenones, the acid-hydrolysis products of benzodiazepines. J Anal Toxicol, 15, 21-24 (1991).
14. Schütz, H.: Benzodiazepines, Springer-Verlag, Berlin, 1982.
15. Schütz, H.: Benzodiazepines II, Springer-Verlag, Berlin, 1989.